It is estimated that 1 out of 20 Americans experience symptomatic hemorrhoids, reported in people of all sexes, ages, ethnicities, and races, as per the Cleveland Clinic. Hemorrhoids are more prevalent in older adults, with over 50% of the population aged 50 and above affected by the condition. The hemorrhoids epidemiology forecast suggests that the prevalence of hemorrhoids is expected to rise over the coming years, primarily due to aging populations, sedentary lifestyles, and dietary factors.
The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hemorrhoids in the 8 major markets.
Common causes of hemorrhoids include straining during bowel movements, obesity, chronic constipation or diarrhea, and pregnancy. A low-fiber diet and lack of physical activity are also significant contributing factors. Hemorrhoids diagnosis is typically clinical, based on patient history and physical examination, including visual inspection, digital rectal exam, or anoscopy for internal hemorrhoids.
The epidemiology of hemorrhoids varies between countries owing to differences in the diet (fiber intake), healthcare access, cultural practices (such as defecation posture), and lifestyle factors like sedentary behavior or obesity. In the United States, about 1 in 20 people are affected by symptomatic hemorrhoids, as per the Cleveland Clinic.
This product will be delivered within 3-5 business days.
Hemorrhoids Epidemiology Forecast Report Coverage
The “Hemorrhoids Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of hemorrhoids. It projects the future incidence and prevalence rates of hemorrhoid cases across various populations. The study covers age, gender, and type as major determinants of the hemorrhoids population. The report highlights patterns in the prevalence of hemorrhoids over time and projects future trends based on multiple variables.The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hemorrhoids in the 8 major markets.
Regions Covered
- The United States
- Germany
- France
- Italy
- Spain
- The United Kingdom
- Japan
- India
Hemorrhoids Understanding: Disease Overview
Hemorrhoids, also known as piles, refer to swollen blood vessels in the lower rectum and anus. Internal hemorrhoids occur inside the rectum and can cause bleeding during bowel movements. They are usually not painful but may prolapse, causing discomfort or pain. External hemorrhoids develop under the skin around the anus.Common causes of hemorrhoids include straining during bowel movements, obesity, chronic constipation or diarrhea, and pregnancy. A low-fiber diet and lack of physical activity are also significant contributing factors. Hemorrhoids diagnosis is typically clinical, based on patient history and physical examination, including visual inspection, digital rectal exam, or anoscopy for internal hemorrhoids.
Hemorrhoids Epidemiology Perspective
The hemorrhoids epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for the hemorrhoids epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hemorrhoids and their trends. The hemorrhoids detailed epidemiology segmentation is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.- In the general population, the overall prevalence of hemorrhoids is reported to be 4.4%, with nearly half of the Americans reported to develop the condition by the time they turn 50.
- In the United States, around 10.4 million to 1 million new cases of hemorrhoids are estimated to occur annually, with 10 to 20% of the new cases needing a surgical intervention.
- Hemorrhoidal disease is considered the third most common outpatient gastrointestinal diagnosis in the United States, with estimates showing that nearly 4 million office and emergency department visits are due to hemorrhoids each year.
Age-Based Hemorrhoids Epidemiology Insights
Various hemorrhoid epidemiological studies suggest that the prevalence of hemorrhoids is the highest in Caucasian patients aged between 45 and 65, and patients having a high socioeconomic status. This age group is at increased risk due to age-related changes in connective tissue and vascular tone, which can contribute to the weakening of the venous structures in the anorectal region. Thus, hemorrhoidal disease becomes more common with advancing age.Gender-Based Hemorrhoids Epidemiology Insights
A 2019 retrospective study analyzing 430 patient admissions for hemorrhoids found that the majority of patients (46%) were in the younger age group (20 to 40 years). The condition was more prevalent in males (69%) compared to females (31%), with the male-to-female ratio estimated to be 2.2:1.Country-wise Hemorrhoids Epidemiology Segment
The hemorrhoids epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.The epidemiology of hemorrhoids varies between countries owing to differences in the diet (fiber intake), healthcare access, cultural practices (such as defecation posture), and lifestyle factors like sedentary behavior or obesity. In the United States, about 1 in 20 people are affected by symptomatic hemorrhoids, as per the Cleveland Clinic.
Hemorrhoids: Treatment Overview
Depending on the severity, treatment for hemorrhoids can range from home remedies and lifestyle changes to medical procedures. Over-the-counter stool softeners can ease bowel movements and reduce strain and discomfort. Over-the-counter creams and ointments are widely used to address inflammation, itching, and pain. Aloe vera gel can also help calm irritation due to its anti-inflammatory properties. Rubber band ligation, sclerotherapy, and infrared coagulation (IRC) are some of the minimally invasive procedures that can be opted by the patients if conventional treatments do not provide relief or if the hemorrhoids are more severe.Key Questions Answered
- What are the key findings of hemorrhoids epidemiology in the 8 major markets?
- What will be the total number of patients with hemorrhoids across the 8 major markets during the forecast period?
- What was the country-wise hemorrhoids epidemiology scenario in the 8 major markets in the historical period?
- Which country will have the highest number of hemorrhoids patients during the forecast period of 2025-2034?
- Which key factors would influence the shift in the patient population of hemorrhoids during the forecast period of 2025-2034?
- What are the currently available treatments in the hemorrhoids market?
- What are the disease risks, signs, symptoms, and unmet needs of hemorrhoids?
Scope of the Hemorrhoids Epidemiology Report
- The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of hemorrhoids based on several factors.
- Hemorrhoids Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
- The hemorrhoids report helps to identify the patient population and the unmet needs are highlighted along with an assessment of the disease's risk and burden.
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Hemorrhoids Market Overview - 8 MM
4 Hemorrhoids Epidemiology Overview - 8 MM
5 Disease Overview
6 Patient Profile
7 Epidemiology Scenario and Forecast - 8 MM (218-2034)
8 Epidemiology Scenario and Forecast: United States (218-2034)
9 Epidemiology Scenario and Forecast: United Kingdom (218-2034)
10 Epidemiology Scenario and Forecast: Germany (218-2034)
11 Epidemiology Scenario and Forecast: France (218-2034)
12 Epidemiology Scenario and Forecast: Italy (218-2034)
13 Epidemiology Scenario and Forecast: Spain (218-2034)
14 Epidemiology Scenario and Forecast: Japan (218-2034)
15 Epidemiology Scenario and Forecast: India (218-2034)